RESUMEN
The possibility of the oral use of heated corpuscular vaccine prepared from S. minnesota mutant R 595 (chemotype Re) for protection against Pseudomonas aeruginosa has been studied. Oral immunization in 3 doses, each containing 10(9) cells of the vaccine strain, has been shown to protect mice from death after the intravenous injection of P. aeruginosa culture in a dose of 5 LD50 and induce a rise in the titers of antibodies to Re-glycolipid (Re-hemagglutinins). After multiple oral administration Re-vaccine shows low acute and chronic toxicity and induces local and systemic immunological transformation.
Asunto(s)
Vacunas Bacterianas/inmunología , Mutación , Salmonella/inmunología , Administración Oral , Animales , Anticuerpos Antibacterianos/análisis , Vacunas Bacterianas/administración & dosificación , Vacunas Bacterianas/toxicidad , Relación Dosis-Respuesta Inmunológica , Evaluación Preclínica de Medicamentos , Inmunización , Dosificación Letal Mediana , Ratones , Infecciones por Pseudomonas/prevención & control , Factores de TiempoRESUMEN
The comparative study of heated corpuscular vaccines prepared from S. minnesota mutant R 595 with defective lipopolysaccharide (LPS), chemotype Re, derived from S. minnesota strain SF 1111 with unchanged LPS, and from P. aeruginosa strain PA 103, was carried out. In contrast to the vaccine from S. minnesota strain SF 1111, the vaccine prepared from the mutant with chemotype Re induced the development of cell-mediated and humoral immunity to P. aeruginosa, and its immunogenicity was close to that of the vaccine from P. aeruginosa strain PA 103.